Elevated risk of severe COVID-19 outcomes among underweight patients in Japan: A national registry-based study
Global Health & Medicine · 31.08.2025 · 7 (4) · 340-346
DOI: 10.35772/ghm.2025.01057 ↗Kurz gefasst
Leserbrief in der Zeitschrift Global Health & Medicine, erschienen am 31.08.2025. Verfasst von Yumi Matsushita und 11 weiteren Autor:innen. Beteiligte Einrichtung: Office of Clinical Research and Education Promotion, Department of Clinical Research Management, Center for Clinical Sciences, Japan Institute for He…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
We conducted a study to determine the impact of body mass index (BMI) (underweight, normal weight, and overweight) on the severity of COVID-19 across different periods of variant predominance using a large-scale data registry of hospitalized COVID-19 patients in Japan (COVIREGI-JP), involving 46,291 Japanese patients aged 20-89 years. Severity was classified based on the most intensive treatment received throughout the hospitalization. Multiple logistic models were used to assess the risk of severe disease, and adjusted odds ratios (ORs) for BMI < 18.5, 18.5-20, and ≥ 25 relative to BMI of 20.1-24.9 were calculated by sex and age group. The risk of severe COVID-19 and death was high among those with BMI < 18.5 [OR (95% CI): 1.88 (1.52-2.33), 1.59 (1.22-2.07)] as well as those with BMI ≥ 25 [1.38 (1.20-1.60), 1.87 (1.50-2.34)] for both men and women, respectively. The risk was extremely high among those with BMI < 18.5 when the Omicron variant was predominant [2.41 (1.66-3.49) for men, 2.96 (1.77-4.97) for women]. An important point to note is that being underweight as well as obesity increased the risk of severe COVID-19 and death. More attention should be paid to underweight individuals when predicting COVID-19 risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Office of Clinical Research and Education Promotion, Department of Clinical Research Management, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan.
- Department of Health Promotion, National Institute of Public Health, Tokyo, Japan.
- Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
- AMR Clinical Reference Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
- Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan.
- Department of Cardiology, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
Zitieren
APA
Matsushita, Y., Yokoyama, T., Hayakawa, K., Saito, S., Matsunaga, N., Terada, M., Suzuki, S., Morioka, S., Kutsuna, S., Hara, H., Kimura, A., & Ohmagari, N. (2025). Elevated risk of severe COVID-19 outcomes among underweight patients in Japan: A national registry-based study. Global Health & Medicine, 7(4), 340-346. https://doi.org/10.35772/ghm.2025.01057
Vancouver
Matsushita Y, Yokoyama T, Hayakawa K, Saito S, Matsunaga N, Terada M, et al. Elevated risk of severe COVID-19 outcomes among underweight patients in Japan: A national registry-based study. Global Health & Medicine. 2025;7(4):340-346. doi:10.35772/ghm.2025.01057
BibTeX
@article{Matsushita2025,
author = {Matsushita, Yumi and Yokoyama, Tetsuji and Hayakawa, Kayoko and Saito, Sho and Matsunaga, Nobuaki and Terada, Mari and Suzuki, Setsuko and Morioka, Shinichiro and Kutsuna, Satoshi and Hara, Hisao and Kimura, Akio and Ohmagari, Norio},
title = {Elevated risk of severe COVID-19 outcomes among underweight patients in Japan: A national registry-based study},
journal = {Global Health & Medicine},
year = {2025},
volume = {7},
number = {4},
pages = {340--346},
doi = {10.35772/ghm.2025.01057}
}
EUVIMED